MUC4 Is a Highly Sensitive and Specific Marker for Low-grade Fibromyxoid Sarcoma

被引:254
作者
Doyle, Leona A. [1 ]
Moeller, Emely [2 ]
Dal Cin, Paola [1 ]
Fletcher, Christopher D. M. [1 ]
Mertens, Fredrik [2 ]
Hornick, Jason L. [1 ]
机构
[1] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA
[2] Lund Univ, Skane Univ Hosp, Univ & Reg Labs, Dept Clin Genet, Lund, Sweden
关键词
soft tissue tumors; sarcoma; immunohistochemistry; translocation; gene expression profiling; SPINDLE-CELL TUMOR; DIAGNOSTIC IMMUNOHISTOCHEMICAL MARKER; GIANT ROSETTES; CLINICOPATHOLOGICAL ANALYSIS; SYNOVIAL SARCOMA; ABERRANT EXPRESSION; MOLECULAR ANALYSIS; GENE-EXPRESSION; FUSION; MUCINS;
D O I
10.1097/PAS.0b013e318210c268
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Low-grade fibromyxoid sarcoma (LGFMS) is a distinctive fibroblastic neoplasm that is characterized by alternating collagenous and myxoid areas, deceptively bland spindle cell morphology, a whorling architecture, and a t(7; 16) translocation involving FUS and CREB3L2. Owing to variable morphology and a lack of discriminatory markers, LGFMS can be difficult to distinguish from benign mesenchymal tumors and other low-grade sarcomas. Gene expression profiling has identified differential upregulation of the mucin 4 (MUC4) gene in LGFMS compared with histologically similar tumors. MUC4 is a transmembrane glycoprotein that functions in cell growth signaling pathways; aberrant MUC4 expression has been reported in various carcinomas. We investigated MUC4 protein expression by immunohistochemistry in LGFMS and in other soft tissue tumors to determine the potential diagnostic use of this novel marker. Whole-tissue sections of 309 tumors were evaluated: 49 LGFMSs (all with FUS gene rearrangement confirmed by fluorescence in situ hybridization), 40 soft tissue perineuriomas, 40 myxofibrosarcomas, 20 cellular myxomas, 20 solitary fibrous tumors, 20 low-grade malignant peripheral nerve sheath tumors, 20 cases of desmoid fibromatosis, 20 neurofibromas, 20 schwannomas, 20 monophasic synovial sarcomas, 20 cases of dermatofibrosarcoma protuberans, 10 myxoid liposarcomas, and 10 extraskeletal myxoid chondrosarcomas. The LGFMS cases included 7 with marked hypercellularity, 4 with prominent hemangiopericytoma-like vessels, 3 with giant collagen rosettes, 3 with epithelioid morphology, 2 with focal nuclear pleomorphism, and 2 with areas of sclerosing epithelioid fibrosarcoma. All 49 LGFMS cases (100%) showed cytoplasmic staining for MUC4, which was usually diffuse and intense. All the other tumor types were negative for MUC4, apart from 6 (30%) monophasic synovial sarcomas. In conclusion, MUC4 is a highly sensitive and quite specific immunohistochemical marker for LGFMS, and can be helpful to distinguish this tumor type from histologic mimics.
引用
收藏
页码:733 / 741
页数:9
相关论文
共 45 条
  • [1] Andrianifahanana M, 2001, CLIN CANCER RES, V7, P4033
  • [2] Membrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cells
    Bafna, S.
    Kaur, S.
    Batra, S. K.
    [J]. ONCOGENE, 2010, 29 (20) : 2893 - 2904
  • [3] MUC4, a Multifunctional Transmembrane Glycoprotein, Induces Oncogenic Transformation of NIH3T3 Mouse Fibroblast Cells
    Bafna, Sangeeta
    Singh, Ajay P.
    Moniaux, Nicolas
    Endy, James D.
    Meza, Jane L.
    Batra, Surinder K.
    [J]. CANCER RESEARCH, 2008, 68 (22) : 9231 - 9238
  • [4] Fusion of the FUS and CREB3L2 genes in a supernumerary ring chromosome in low-grade fibromyxoid sarcoma
    Bartuma, Hammurabi
    Moller, Emely
    Collin, Anna
    Domanski, Henryk A.
    Von Steyern, Fredrik Vult
    Mandahl, Nils
    Mertens, Fredrik
    [J]. CANCER GENETICS AND CYTOGENETICS, 2010, 199 (02) : 143 - 146
  • [5] Bejarano PA, 2000, ARCH PATHOL LAB MED, V124, P1179
  • [6] Superficial low-grade fibromyxoid sarcoma (Evans tumor) - A clinicopathologic analysis of 19 cases with a unique observation in the pediatric population
    Billings, SD
    Giblen, G
    Fanburg-Smith, JC
    [J]. AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (02) : 204 - 210
  • [7] Muc4/MUC4 functions and regulation in cancer
    Carraway, Kermit L.
    Theodoropoulos, George
    Kozloski, Goldi A.
    Carraway, Coralie A. Carothers
    [J]. FUTURE ONCOLOGY, 2009, 5 (10) : 1631 - 1640
  • [8] Muc4/sialomucin complex, the intramembrane ErbB2 ligand, in cancer and epithelia: To protect and to survive
    Carraway, KL
    Perez, A
    Idris, N
    Jepson, S
    Arango, M
    Komatsu, M
    Haq, B
    Price-Schiavi, SA
    Zhang, J
    Carraway, CAC
    [J]. PROGRESS IN NUCLEIC ACID RESEARCH AND MOLECULAR BIOLOGY, VOL 71, 2002, 71 : 149 - 185
  • [9] Structure, evolution, anal biology of the MUC4 mucin
    Chaturvedi, Pallavi
    Singh, Ajay P.
    Batra, Surinder K.
    [J]. FASEB JOURNAL, 2008, 22 (04) : 966 - 981
  • [10] MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells
    Chaturvedi, Pallavi
    Singh, Ajay P.
    Chakraborty, Subhankar
    Chauhan, Subhash C.
    Bafna, Sangeeta
    Meza, Jane L.
    Singh, Pankaj K.
    Hollingsworth, Michael A.
    Mehta, Parmender P.
    Batra, Surinder K.
    [J]. CANCER RESEARCH, 2008, 68 (07) : 2065 - 2070